The Supreme Court of New South Wales has approved the scheme of arrangement for SDI Limited’s acquisition by Beijing Guoci’s subsidiary, paving the way for a cash payout and ASX suspension.
- Supreme Court approves SDI acquisition scheme
- Acquisition price set at A$1.40 per share in cash
- Scheme expected effective 25 June 2026
- SDI shares to be suspended from ASX on 25 June
- Implementation date targeted for 6 July 2026
Court Approval Clears Final Legal Hurdle
SDI Limited (ASX:SDI) has secured a critical milestone in its acquisition journey after the Supreme Court of New South Wales today approved the scheme of arrangement under which InnoXvest Dental Pty. Ltd, a subsidiary of Beijing Guoci Kebo Technology Co., Ltd, will acquire 100% of SDI’s shares. The court’s endorsement means the scheme is expected to become effective upon lodgement with ASIC on 25 June 2026.
Cash Consideration and Shareholder Payout Timeline
The acquisition values SDI shares at A$1.40 each, payable in cash to shareholders recorded on the company’s register at 7:00pm Sydney time on 29 June 2026. The implementation date for the scheme is scheduled for 6 July 2026, when payments will be made to eligible shareholders. This offer price reflects the agreed terms between SDI and the Beijing Guoci-controlled bidder, following strong shareholder support in recent votes.
ASX Suspension and Market Impact
Trading in SDI shares will be suspended from the close of trading on 25 June 2026, coinciding with the scheme’s effectiveness. This suspension marks the last day SDI shares will be available on the ASX before delisting. The move concludes a process that began with the company’s announcement of the acquisition offer earlier this year and has since navigated regulatory approvals and shareholder meetings.
Strategic Backing and Industry Positioning
SDI, a Melbourne-based manufacturer known for its specialist dental materials distributed globally, is set to join the portfolio of Beijing Guoci and its parent Shandong Sinocera Functional Material Co., Ltd, a Shenzhen-listed advanced materials company. This acquisition aligns with Sinocera’s expansion into healthcare-related materials and reinforces its footprint in dental products across international markets.
Next Steps and Shareholder Considerations
While all dates remain indicative and subject to change, shareholders should prepare for the transition and cash receipt in early July. SDI’s board and advisers, including Houlihan Lokey and DLA Piper, continue to provide guidance as the scheme moves to implementation. The acquisition closes a chapter on SDI’s public listing after more than four decades, shifting ownership to a China-based conglomerate with global ambitions in functional materials and dental healthcare.
Bottom Line?
With court approval secured, SDI’s acquisition shifts into execution mode, leaving shareholders to await the final cash payout and the stock’s exit from the ASX.
Questions in the middle?
- How will Beijing Guoci integrate SDI into its existing dental and materials businesses?
- What operational changes might follow post-acquisition for SDI’s manufacturing in Victoria?
- Could this deal signal further consolidation in the dental materials sector?